In this thought-provoking episode, we sit down with Dylan Beynon, founder and CEO of Mindbloom, to explore how psychedelic-assisted therapy is reshaping the future of mental health care. Mindbloom is at the forefront of at-home ketamine therapy, providing guided sessions for people struggling with depression, anxiety, and PTSD — and since 2018, the company has facilitated more than 650,000 transformative experiences across the U.S.

Dylan’s mission is deeply personal, rooted in his own family’s struggles with mental illness and addiction. Through Mindbloom, he’s creating a path toward accessible, safe, and science-backed healing — while helping dismantle the stigma around psychedelic medicine.

Tune in to learn:

• How guided psychedelic therapy works and its proven benefits.
• What the latest research says about ketamine and neuroplasticity.
• How mental health narratives are shaped by Big Pharma and cultural bias.
• Why the next frontier in psychiatry may lie in psychedelic integration.

Whether you’re curious about the ethics, science, or personal impact of psychedelic therapy, this episode shines a light on how Mindbloom is redefining what’s possible in modern mental wellness.

Visit here to learn more about Dylan’s groundbreaking work.

Episode also available on Apple Podcasts: https://apple.co/38oMlMr

Keep up with Dylan Beynon socials here:

Facebook: https://www.facebook.com/profile.php?id=100087449081875

X: https://x.com/dylanbeynon

🛍️ Recommended Products & Reads from This Episode:

• 🎙️ Blue Yeti USB Microphone – A top choice for aspiring podcasters and speakers who want professional-grade audio at home.
  👉Check it out

Note: These are affiliate links. If you make a purchase through them, we may earn a small commission at no extra cost to you. It helps support the podcast. Thank you!

Podcast: Play in new window | Download | Embed